Skip to main content
Top
Published in: Diabetologia 8/2010

Open Access 01-08-2010 | Short Communication

Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) study

Authors: R. Borg, J. C. Kuenen, B. Carstensen, H. Zheng, D. M. Nathan, R. J. Heine, J. Nerup, K. Borch-Johnsen, D. R. Witte, on behalf of the ADAG Study Group

Published in: Diabetologia | Issue 8/2010

Login to get access

Abstract

Aims/hypothesis

Real-life glycaemic profiles of healthy individuals are poorly studied. Our aim was to analyse to what extent individuals without diabetes exceed OGTT thresholds for impaired glucose tolerance (IGT) and diabetes.

Methods

In the A1C-Derived Average Glucose (ADAG) study, 80 participants without diabetes completed an intensive glucose monitoring period of 12 weeks. From these data, we calculated the average 24 h glucose exposure as time spent above different plasma glucose thresholds. We also derived indices of postprandial glucose levels, glucose variability and HbA1c.

Results

We found that 93% of participants reached glucose concentrations above the IGT threshold of 7.8 mmol/l and spent a median of 26 min/day above this level during continuous glucose monitoring. Eight individuals (10%) spent more than 2 h in the IGT range. They had higher HbA1c, fasting plasma glucose (FPG), age and BMI than those who did not. Seven participants (9%) reached glucose concentrations above 11.1 mmol/l during monitoring.

Conclusions/interpretation

Even though the non-diabetic individuals monitored in the ADAG study were selected on the basis of a very low level of baseline FPG, 10% of these spent a considerable amount of time at glucose levels considered to be ‘prediabetic’ or indicating IGT. This highlights the fact that exposure to moderately elevated glucose levels remains under-appreciated when individuals are classified on the basis of isolated glucose measurements.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation, part 1: diagnosis and classification of diabetes mellitus. WHO, Geneva World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation, part 1: diagnosis and classification of diabetes mellitus. WHO, Geneva
2.
go back to reference Nathan DM, Kuenen J, Borg R et al (2008) Translating the A1C assay into estimated average glucose values. Diabetes Care 31:1473–1478CrossRefPubMed Nathan DM, Kuenen J, Borg R et al (2008) Translating the A1C assay into estimated average glucose values. Diabetes Care 31:1473–1478CrossRefPubMed
3.
4.
go back to reference Mazze RS, Strock E, Wesley D et al (2008) Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. Diabetes Technol Ther 10:149–159CrossRefPubMed Mazze RS, Strock E, Wesley D et al (2008) Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. Diabetes Technol Ther 10:149–159CrossRefPubMed
5.
go back to reference Derosa G, Salvadeo SAT, Mereu R et al (2009) Continuous glucose monitoring system in free-living healthy subjects: results from a pilot study. Diabetes Technol Ther 11:159–169CrossRefPubMed Derosa G, Salvadeo SAT, Mereu R et al (2009) Continuous glucose monitoring system in free-living healthy subjects: results from a pilot study. Diabetes Technol Ther 11:159–169CrossRefPubMed
6.
go back to reference Abdul-Ghani MA, Tripathy D, DeFronzo RA (2006) Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29:1130–1139CrossRefPubMed Abdul-Ghani MA, Tripathy D, DeFronzo RA (2006) Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29:1130–1139CrossRefPubMed
7.
go back to reference No authors listed (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327–1334 No authors listed (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327–1334
Metadata
Title
Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) study
Authors
R. Borg
J. C. Kuenen
B. Carstensen
H. Zheng
D. M. Nathan
R. J. Heine
J. Nerup
K. Borch-Johnsen
D. R. Witte
on behalf of the ADAG Study Group
Publication date
01-08-2010
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 8/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-010-1741-9

Other articles of this Issue 8/2010

Diabetologia 8/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine